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Interest into the health, disease, and performance impact of exogenous ketone bodies has rapidly 
expanded due to their multifaceted physiological and signaling properties but limiting our understanding 
is the isolated analyses of individual types and dose/dosing protocols. PURPOSE: To explore both the 
administration and dose response of βHB+MCT on metabolic, physiological, perceptual, physical 
performance and cognitive performance parameters. METHODS: Thirteen recreational male distance 
runners (24.8±9.6y, 72.5±8.3kg, VO2max 60.1±5.4ml/kg/min) participated in this randomized, double-
blind, crossover design study. The first two sessions consisted of a 5-km running time trial (TT) 
familiarization and a VO2max test. During subsequent trials, subjects were randomly assigned to one 
(KS1:22.1g) or two (KS2:44.2g) doses of beta-hydroxybutyrate (βHB) and medium chain triglycerides 
(MCTs) or flavor matched placebo (PLA). Blood R-βHB, glucose, and lactate concentrations were 
measured at baseline (0-min), post-supplement (30 & 60mins), post-exercise (+0min, +15mins). Time, 
heart rate (HR), rating of perceived exertion (RPE), affect, respiratory exchange ratio (RER), oxygen 
consumption (VO2), carbon dioxide production (VCO2), and ventilation (VE) were measured during 
exercise. Cognitive performance was evaluated prior to and post-exercise. RESULTS: KS significantly 
increased R-βHB, with more potent (60min post-KS; KS1: 0.73±0.2mM; KS2: 0.60±0.2mM) and 
prolonged (+15min post-exercise; KS1: 0.28±0.1mM; KS2: 0.59±0.3mM) elevations in KS2. R-βHB 
was significantly decreased in KS1 compared to KS2. Blood lactate significantly increased post-exercise 
but was augmented by KS administration (PLA: 6.1±2.2mM; KS1: 7.2±2.5mM; KS2: 7.1±2.5mM). 
Gaseous exchange, respiration, HR, affect, RPE, and exercise performance was unaltered with KS 
administration. KS2 significantly augmented cognitive function in pre-exercise conditions (Reaction 
Time; PLA: 728.3±143.3ms; KS1: 707.9±156.7ms; KS2: 622.6 ± 98.8ms). CONCLUSION: Novel 
βHB+MCT formulation had a dosing effect on R-βHB and cognitive performance, an administrative 
response on blood lactate, while not influencing gaseous exchange, respiration, HR, affect, RPE, and 
exercise performance.   
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